Care Costs
By A&U | April 28th, 2011 | Category: Hep Talk, LifeGuide | Comments OffLifeGuide [Hep Talk] New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in the pipeline to treat hepatitis C, the most common cause of chronic liver disease, liver cancer, and liver transplantation in the U.S. When these meds become available they promise improved health-related quality of life and reduced morbidity and mortality, provided they are taken as recommended. And provided patients can afford them. That’s a big problem given their [...]